FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131206723> ?p ?o ?g. }

• W2131206723 endingPage "3396" @default.
• W2131206723 startingPage "3389" @default.
• W2131206723 abstract "Purpose To evaluate the effect on outcome of intensifying therapy for patients with acute lymphoblastic leukemia (ALL) and an intrachromosomal amplification of chromosome 21 (iAMP21). Patients and Methods We report two cohorts of patients treated on Medical Research Council ALL97 or United Kingdom (UK) ALL2003. iAMP21 was identified retrospectively in ALL97 and was not used to guide therapy. However, in UKALL2003, iAMP21 was determined prospectively, and patients were allocated to the most intensive treatment arm (regimen C), which included augmented Berlin-Frankfurt-Munster consolidation, escalating Capizzi maintenance, double delayed intensification, and an option for first remission transplantation. The presence of iAMP21 was determined by fluorescence in situ hybridization using probes specific for the RUNX1 gene. Results iAMP21 was identified in 2% of patients with B-cell precursor ALL treated on UKALL2003 and ALL97. The event-free survival, relapse, and overall survival rates at 5 years for iAMP21 patients treated on ALL97 and UKALL2003 were 29% and 78%, 70% and 16%, and 67% and 89%, respectively (all P < .01). Patients treated on ALL97 had an increased risk of relapse compared with patients treated on UKALL2003 (hazard ratio, 7.2; 95% CI, 2.91 to 17.87; P < .001). Conclusion iAMP21 patients with ALL benefitted from receiving more intensive therapy in UKALL2003. In UKALL2011, they will continue to be treated as cytogenetic high risk, receive intensive chemotherapy (regimen C), and will only be recommended for transplantation if they do not achieve a complete remission by the end of induction therapy. This study illustrates how the discovery and characterization of disease-specific genetic aberrations can be used to tailor therapy more precisely." @default.
• W2131206723 created "2016-06-24" @default.
• W2131206723 creator A5013368749 @default.
• W2131206723 creator A5021778068 @default.
• W2131206723 creator A5032713965 @default.
• W2131206723 creator A5050141938 @default.
• W2131206723 creator A5066319509 @default.
• W2131206723 creator A5066362816 @default.
• W2131206723 creator A5081337364 @default.
• W2131206723 creator A5082401017 @default.
• W2131206723 creator A5085120275 @default.
• W2131206723 date "2013-09-20" @default.
• W2131206723 modified "2023-10-18" @default.
• W2131206723 title "Risk-Directed Treatment Intensification Significantly Reduces the Risk of Relapse Among Children and Adolescents With Acute Lymphoblastic Leukemia and Intrachromosomal Amplification of Chromosome 21: A Comparison of the MRC ALL97/99 and UKALL2003 Trials" @default.
• W2131206723 cites W1969474327 @default.
• W2131206723 cites W1969979664 @default.
• W2131206723 cites W1984633396 @default.
• W2131206723 cites W1988877817 @default.
• W2131206723 cites W2004652425 @default.
• W2131206723 cites W2014561096 @default.
• W2131206723 cites W2016833582 @default.
• W2131206723 cites W2030176292 @default.
• W2131206723 cites W2032311991 @default.
• W2131206723 cites W2035166663 @default.
• W2131206723 cites W2037037639 @default.
• W2131206723 cites W2038604255 @default.
• W2131206723 cites W2060033869 @default.
• W2131206723 cites W2062879364 @default.
• W2131206723 cites W2070962119 @default.
• W2131206723 cites W2071899049 @default.
• W2131206723 cites W2096336184 @default.
• W2131206723 cites W2096875118 @default.
• W2131206723 cites W2100512258 @default.
• W2131206723 cites W2106867586 @default.
• W2131206723 cites W2111606093 @default.
• W2131206723 cites W2117692326 @default.
• W2131206723 cites W2120326840 @default.
• W2131206723 cites W2121121242 @default.
• W2131206723 cites W2141869972 @default.
• W2131206723 cites W2147262371 @default.
• W2131206723 cites W2163926478 @default.
• W2131206723 cites W2326181393 @default.
• W2131206723 doi "https://doi.org/10.1200/jco.2013.48.9377" @default.
• W2131206723 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23940220" @default.
• W2131206723 hasPublicationYear "2013" @default.
• W2131206723 type Work @default.
• W2131206723 sameAs 2131206723 @default.
• W2131206723 citedByCount "97" @default.
• W2131206723 countsByYear W21312067232013 @default.
• W2131206723 countsByYear W21312067232014 @default.
• W2131206723 countsByYear W21312067232015 @default.
• W2131206723 countsByYear W21312067232016 @default.
• W2131206723 countsByYear W21312067232017 @default.
• W2131206723 countsByYear W21312067232018 @default.
• W2131206723 countsByYear W21312067232019 @default.
• W2131206723 countsByYear W21312067232020 @default.
• W2131206723 countsByYear W21312067232021 @default.
• W2131206723 countsByYear W21312067232022 @default.
• W2131206723 countsByYear W21312067232023 @default.
• W2131206723 crossrefType "journal-article" @default.
• W2131206723 hasAuthorship W2131206723A5013368749 @default.
• W2131206723 hasAuthorship W2131206723A5021778068 @default.
• W2131206723 hasAuthorship W2131206723A5032713965 @default.
• W2131206723 hasAuthorship W2131206723A5050141938 @default.
• W2131206723 hasAuthorship W2131206723A5066319509 @default.
• W2131206723 hasAuthorship W2131206723A5066362816 @default.
• W2131206723 hasAuthorship W2131206723A5081337364 @default.
• W2131206723 hasAuthorship W2131206723A5082401017 @default.
• W2131206723 hasAuthorship W2131206723A5085120275 @default.
• W2131206723 hasBestOaLocation W21312067231 @default.
• W2131206723 hasConcept C126322002 @default.
• W2131206723 hasConcept C143998085 @default.
• W2131206723 hasConcept C187212893 @default.
• W2131206723 hasConcept C207103383 @default.
• W2131206723 hasConcept C2778461978 @default.
• W2131206723 hasConcept C2781413609 @default.
• W2131206723 hasConcept C2909962599 @default.
• W2131206723 hasConcept C2911091166 @default.
• W2131206723 hasConcept C44249647 @default.
• W2131206723 hasConcept C71924100 @default.
• W2131206723 hasConceptScore W2131206723C126322002 @default.
• W2131206723 hasConceptScore W2131206723C143998085 @default.
• W2131206723 hasConceptScore W2131206723C187212893 @default.
• W2131206723 hasConceptScore W2131206723C207103383 @default.
• W2131206723 hasConceptScore W2131206723C2778461978 @default.
• W2131206723 hasConceptScore W2131206723C2781413609 @default.
• W2131206723 hasConceptScore W2131206723C2909962599 @default.
• W2131206723 hasConceptScore W2131206723C2911091166 @default.
• W2131206723 hasConceptScore W2131206723C44249647 @default.
• W2131206723 hasConceptScore W2131206723C71924100 @default.
• W2131206723 hasIssue "27" @default.
• W2131206723 hasLocation W21312067231 @default.
• W2131206723 hasLocation W21312067232 @default.
• W2131206723 hasOpenAccess W2131206723 @default.
• W2131206723 hasPrimaryLocation W21312067231 @default.
• W2131206723 hasRelatedWork W2351826232 @default.
• W2131206723 hasRelatedWork W2373073571 @default.
• W2131206723 hasRelatedWork W2377136501 @default.

• next